Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (75 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Exciting News did nothing for share price
View:
Post by gonefishing2022 on Aug 13, 2024 6:28pm

Exciting News did nothing for share price

I will ask the same question as yesterday do anjy of you think this will be above 1 dollar before end of year or 1 to 5 Dollars. I'm thinking this will not go anywhere until full approval in 2026.
Management has screwed up timedays and have there heads I  clouds with big evaluation instead of getting the Job Done. 
Approval Approval no more wasinh time but this looks like to me 2026 until it flys
Comment by Kayz88 on Aug 13, 2024 6:31pm
I think it'll move with BTD. It gives a bit more substance than the FTD. When we received FTD, we had a small pop till they realized it was the equivalent to being accepted to the Disney genie line
Comment by Legit62 on Aug 13, 2024 7:42pm
This will most likely be bought out before FDA approval IMO, and north of $10 a share , thats our ticket, we need BTD and AA first, but Big Pharma will not let this ride beyond that because of all the indications we have.
Comment by skier59 on Aug 13, 2024 7:50pm
You know what, none of us could figure out what the true results were over the years. I laughed as the group was debating the true numbers. No wonder the FDA wanted more exact clarity on our results, as we always wished. I think the results have been great since that initial fluckup of the first dirty dozen. Always wondered who was responsible for that mess ?? Really set us back !
Comment by Galaxym31 on Aug 13, 2024 7:56pm
Sadly it looks like the warrants are a complete loss zero nil nadda done .
Comment by chry200030 on Aug 13, 2024 8:38pm
$10 dollars a share... We are looking at a number way north of that. And if there are multiple bidders, lookout. I have a 3 digit number per share if all goes well. Let's be patient and let them comlete their work.  Yea, we have to wait .a bt longer but it's money in the bank. NO BUYOUT for at least another 30-40 months...
Comment by CancerSlayer on Aug 13, 2024 10:08pm
chry...30-40 months?  If I were only younger/healthier ; ).   Enjoyed reading everyone's posts today...healthy insight from different angles.  BK and J&R...agree.  The usual thanks to Eoganacht, Dawg & others...CS. Come Vegas time, I'll foot the water bill.
Comment by gojotv! on Aug 14, 2024 12:58am
Glad to hear I'm not the only one holding out for $300+ per share. After all, this is better and less diluted than Apple, Amazon, Tesla, etc. so... time is money. Hold out as long as you can!
Comment by 2b7f6fab on Aug 13, 2024 11:09pm
Difficult to say how the market will react when awarded BTD.  Personally I think we'll get BTD and AA given the excellent CRs to date. bwdik.  After these 57 million warrants expire in 10 days or so there will still be 34 million warrants outstanding with exercise prices of 25 and 35 cents. What if BTD doesn't move the needle much and the stock price only moves to 30 cents, or a ...more  
Comment by DJDawg on Aug 14, 2024 10:11am
The challenging thing about talking about how the "market reacts" is that the TSX V is so small and TLT small within it that the market is mostly unaware? The reactions we see are from a very small subset of the market compared to a NASDAQ company. So I hesitate to say much about the market reactions to TLT. More like the small pool of people who follow or know about TLT have reacted ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 75 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 72 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250